PZ Cormay S.A. (WSE: CRM)

Market Cap	41.26M
Revenue (ttm)	84.06M
Net Income (ttm)	-4.83M
Shares Out	84.21M
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	62,747
Open	0.490
Previous Close	0.490
Day's Range	0.480 - 0.500
52-Week Range	0.470 - 0.710
Beta	0.64
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 20, 2024

About PZ Cormay

PZ Cormay S.A. develops, manufactures, and sells diagnostic reagents in Poland. It offers testing products for clinical chemistry, electrophoresis, hematology, veterinary, coagulology, blood group serology, immunology, immunochemistry, molecular biology, sampling, oncological surgery, and general analytics, as well as vacuum blood collection system. The company offers its products under the Orphée and Diesse brand names. The company also exports its products to approximately 150 countries, including Germany, Austria, France, Greece, Turkey, Ind...

• Industry: Hardware, Equipment & Parts
• Sector: Technology
• Founded: 1985
• Employees: 222
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: CRM